Not currently approved for paediatric use.
At present, there is not enough data to determine the safety in the elderly.
In women with IBD who are pregnant or attempting conception, we suggest continuing maintenance ustekinumab therapy throughout pregnancy.
Women with IBD who are pregnant or attempting conception should continue biosimilar to existing biologics.13